These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 28376205)
1. Association of Uba6-Specific-E2 (USE1) With Lung Tumorigenesis. Kim SJ; Hyeong Lee T; Hee Nam S; Kim JH; Oh S; Sook Cho Y; Sup Lee M; Choi S; Lee PC J Natl Cancer Inst; 2017 Mar; 109(3):1-11. PubMed ID: 28376205 [TBL] [Abstract][Full Text] [Related]
2. LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6. Wu C; Liu Y; Gu X; Zhu T; Yang S; Sun W Biochem Biophys Res Commun; 2016 Sep; 478(3):1442-8. PubMed ID: 27569286 [TBL] [Abstract][Full Text] [Related]
3. UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10. Wang F; Zhao B Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067743 [TBL] [Abstract][Full Text] [Related]
4. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1. Aichem A; Catone N; Groettrup M FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925 [TBL] [Abstract][Full Text] [Related]
5. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M Nat Commun; 2010 May; 1():13. PubMed ID: 20975683 [TBL] [Abstract][Full Text] [Related]
6. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Jin J; Li X; Gygi SP; Harper JW Nature; 2007 Jun; 447(7148):1135-8. PubMed ID: 17597759 [TBL] [Abstract][Full Text] [Related]
7. Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins. Lee PC; Sowa ME; Gygi SP; Harper JW Mol Cell; 2011 Aug; 43(3):392-405. PubMed ID: 21816346 [TBL] [Abstract][Full Text] [Related]
8. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation. Bialas J; Groettrup M; Aichem A PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649 [TBL] [Abstract][Full Text] [Related]
9. Suppression of Lung Cancer Malignancy by Micellized siRNA through Cell Cycle Arrest. Kim H; Jeong IH; Choi YK; Lee YK; Moon E; Huh YH; Im W; Jin JO; Kwak M; Lee PC Adv Healthc Mater; 2023 Apr; 12(11):e2202358. PubMed ID: 36644959 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer. Lo FY; Chen HT; Cheng HC; Hsu HS; Wang YC Lung Cancer; 2012 Sep; 77(3):585-92. PubMed ID: 22749159 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer. Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716 [TBL] [Abstract][Full Text] [Related]
13. Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system. Lee PC; Dodart JC; Aron L; Finley LW; Bronson RT; Haigis MC; Yankner BA; Harper JW Mol Cell; 2013 Apr; 50(2):172-84. PubMed ID: 23499007 [TBL] [Abstract][Full Text] [Related]
14. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814 [TBL] [Abstract][Full Text] [Related]
15. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164 [TBL] [Abstract][Full Text] [Related]
16. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180 [TBL] [Abstract][Full Text] [Related]
18. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238 [TBL] [Abstract][Full Text] [Related]
19. Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma. Song Y; Sun B; Hao L; Hu J; Du S; Zhou X; Zhang L; Liu L; Gong L; Chi X; Liu Q; Shao S Oncotarget; 2016 Sep; 7(36):58470-58482. PubMed ID: 27542262 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer. He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]